510(k) for ESTECH's perfusion cannula:
This article was originally published in Clinica
ESTECH has received marketing clearance from the US FDA for its remote access perfusion cannula. The device is designed to stop the heart and provide arterial blood flow, allowing cardiac surgery to be performed in a less invasive way through small incisions between the ribs. The multi-function ESTECH cannula delivers blood flow directly to the central aorta in its natural direction unlike other devices which provide blood flow in the opposite direction. Reverse blood flow has been implicated in the occurrences of aortic tears, said the Danville, California-based company.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.